- Home
- OLED vs LEGN Comparison
OLED vs LEGN Comparison
Compare OLED & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLED
- LEGN
- Stock Information
- Founded
- OLED 1985
- LEGN 2014
- Country
- OLED United States
- LEGN United States
- Employees
- OLED N/A
- LEGN N/A
- Industry
- OLED Semiconductors
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- OLED Technology
- LEGN Health Care
- Exchange
- OLED Nasdaq
- LEGN Nasdaq
- Market Cap
- OLED 7.2B
- LEGN 7.0B
- IPO Year
- OLED 1992
- LEGN 2020
- Fundamental
- Price
- OLED $142.10
- LEGN $32.04
- Analyst Decision
- OLED Strong Buy
- LEGN Strong Buy
- Analyst Count
- OLED 7
- LEGN 13
- Target Price
- OLED $190.43
- LEGN $79.42
- AVG Volume (30 Days)
- OLED 780.7K
- LEGN 1.5M
- Earning Date
- OLED 05-01-2025
- LEGN 05-13-2025
- Dividend Yield
- OLED 1.27%
- LEGN N/A
- EPS Growth
- OLED 4.58
- LEGN N/A
- EPS
- OLED 4.81
- LEGN N/A
- Revenue
- OLED $648,702,000.00
- LEGN $627,241,000.00
- Revenue This Year
- OLED $5.35
- LEGN $65.96
- Revenue Next Year
- OLED $13.88
- LEGN $52.55
- P/E Ratio
- OLED $29.54
- LEGN N/A
- Revenue Growth
- OLED 6.13
- LEGN 119.97
- 52 Week Low
- OLED $103.70
- LEGN $29.27
- 52 Week High
- OLED $237.00
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- OLED 60.34
- LEGN 42.63
- Support Level
- OLED $139.13
- LEGN $33.91
- Resistance Level
- OLED $146.50
- LEGN $35.81
- Average True Range (ATR)
- OLED 5.65
- LEGN 1.41
- MACD
- OLED 3.39
- LEGN -0.16
- Stochastic Oscillator
- OLED 87.74
- LEGN 32.26
About OLED Universal Display Corporation
Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.